Rayzon
Active Substance: parecoxib
Common Name: parecoxib
ATC Code: M01AH04
Marketing Authorisation Holder: Pharmacia Europe EEIG
Active Substance: parecoxib
Status: Withdrawn
Authorisation Date: 2002-03-22
Therapeutic Area: Pain, Postoperative
Pharmacotherapeutic Group: Antiinflammatory and antirheumatic products
Therapeutic indication
For the short-term treatment of postoperative pain.
The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the
individual patient's overall risks (see sections 4.3, 4.4).
The marketing authorisation for Rayzon has been withdrawn at the request of the marketing authorisation holder.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
